Skip to main content

View full-text article in PMC

. 2022 Sep 2;9:965130. doi: 10.3389/fnut.2022.965130

Table 1.

Baseline sociodemographic and clinical characteristics.

		Placebo (n = 50)	Ocimum tenuiflorum (n = 50)	p -value
Age	Mean	44.16	45.96	0.442^a
	SE	1.72	1.57
Sex	Female (n)	30	34	0.405^b
	Male (n)	20	16
BMI	Mean	26.08	26.49	0.595^a
	SE	0.49	0.59
Marital status	Single	20	19	0.838^b
	Married/ defacto	30	31
Educational level	Secondary	24	22	0.840^b
	Tertiary	15	18
	Post-graduate	10	10
IPAC category	Low	28	25	0.703^b
	Moderate	16	20
	High	6	5
PSS	Mean	22.16	21.78	0.701^a
	SE	0.74	0.66
AIS	Mean	12.14	11.34	0.946^a
	SE	0.51	0.43
RSQ	Mean	37.72	38.11	0.230^a
	SE	1.91	2.01
POMS-A Total mood	Mean	117.22	111.72	0.213^a
disturbance	SE	3.74	2.28
PROMIS-29 Physical	Mean	4.94	4.68	0.402^a
function	SE	0.22	0.22
PROMIS-29 Anxiety	Mean	9.24	0.47	0.342^a
	SE	0.47	0.38
PROMIS-29 Depression	Mean	7.48	6.62	0.190^a
	SE	0.47	0.45
PROMIS-29 Fatigue	Mean	13.28	12.92	0.622^a
	SE	0.55	0.48
PROMIS-29 Sleep disturbances	Mean	14.80	14.68	0.834^a
	SE	0.43	0.37
PROMIS-29 Ability to	Mean	10.02	10.34	0.610^a
participate in social	SE	0.43	0.46
roles and activities	SE	0.32	0.33
Total sleep time (Fitbit)	Mean	416.99	417.26	0.980^a
(min)	SE	8.81	6.10
Time in bed (Fitbit)	Mean	478.18	478.98	0.902^a
(min)	SE	9.28	7.01
Sleep efficiency (Fitbit)	Mean	87.49	87.39	0.944^a
(%)	SE	0.70	0.52

^a

independent samples t-test,

^b

chi-square analysis.